Homocysteine: The hidden biomarker of aging (and the centenarian paradox)

There’s a number in your blood tests that your doctor probably rarely checks — yet it could tell you how fast your DNA is aging.

It’s not cholesterol, it’s not blood sugar, it’s not even creatinine. It’s homocysteine — an amino acid produced from methionine metabolism that, when it accumulates, accelerates epigenetic aging, damages blood vessels, and increases the risk of dementia.

The paradox? 77-100% of centenarians have elevated homocysteine levels. Yet they live past 100 years.

In 2024, a study published in Aging Cell demonstrated for the first time that normalizing homocysteine with B vitamins not only reduces blood levels but slows biological aging measured by epigenetic clocks. Two years of supplementation produced a measurable deceleration of aging.

In this article, we explain what the science says, why “normal” lab values aren’t optimal for longevity, and what you can do concretely to optimize your homocysteine.

What you’ll learn:

• What homocysteine is and how methylation works
• Normal values vs. optimal values for longevity
• The centenarian paradox: high homocysteine and long life
• Homocysteine and epigenetic aging: what the research says
• Risks of high homocysteine: heart, brain, kidneys, and bones
• Causes of elevated homocysteine (including MTHFR mutations)
• How to lower homocysteine naturally: 7 evidence-based strategies
• When to test and how to interpret results
• How SuperAge integrates homocysteine into the longevity picture
• FAQ

---

What Is Homocysteine?

Homocysteine is a sulfur-containing amino acid that the body produces as an intermediate in methionine metabolism — an essential amino acid we obtain from dietary proteins (meat, fish, eggs, dairy).

Quick definition: Homocysteine is an amino acid produced from the breakdown of methionine. Under normal conditions, it’s quickly recycled or eliminated thanks to B vitamins. When it accumulates in the blood, it becomes a marker of metabolic stress, inflammation, and accelerated aging.

Homocysteine itself isn’t “bad.” It’s a necessary step in metabolism. The problem arises when the body can’t clear it fast enough — and blood levels rise.

The Methylation Cycle: Why It Matters

To understand homocysteine, you need to understand methylation — one of the most fundamental biochemical processes in the body.

Methylation is the transfer of a methyl group (CH₃) from one molecule to another. This process:

• Regulates gene expression — turns genes on and off through DNA methylation
• Repairs DNA — maintains genetic integrity
• Produces neurotransmitters — serotonin, dopamine, adrenaline
• Detoxifies the liver — eliminates toxins and drugs
• Maintains myelin — the protective sheath of nerves

The cycle works like this:

1. Methionine (from food) is converted to SAM (S-adenosyl-methionine), the body’s “universal methyl donor”
2. SAM donates its methyl group (to DNA, proteins, neurotransmitters…) and becomes SAH (S-adenosyl-homocysteine)
3. SAH is converted to homocysteine
4. Homocysteine is recycled in two ways:
   • Remethylation pathway: returns to methionine via vitamin B12 and folate (B9) — and here MTHFR genetic variants become critical, as they impair the conversion of dietary folate into the active methylfolate form
   • Transsulfuration pathway: converts to cysteine via vitamin B6

When one of these pathways gets blocked — due to B vitamin deficiency, genetic mutations, or other factors — homocysteine accumulates.

Homocysteine and Epigenetic Clocks

The connection to aging is direct: DNA methylation is the central mechanism of epigenetic clocks (like Horvath and GrimAge) used to measure biological age. When methylation doesn’t work properly — which happens when homocysteine is elevated — the DNA methylation pattern becomes altered, and the biological clock accelerates.

---

Normal Values vs. Optimal Values: The Difference That Matters

This is where conventional medicine and longevity science significantly diverge.

Level	Value (µmol/L)	Interpretation
Optimal for longevity	4 - 8	Range associated with minimum cardiovascular risk and slowed aging
Acceptable	8 - 10	Good, but room for improvement
Suboptimal	10 - 12	Within “normal” lab range, but mortality risk increasing
Elevated	12 - 15	Increased cardiovascular and cognitive risk
High	15 - 30	Mild hyperhomocysteinemia — intervention needed
Very high	30 - 100	Moderate hyperhomocysteinemia — urgent investigation required
Critical	> 100	Homocystinuria — severe genetic condition

Most labs indicate as “normal” any value up to 15 µmol/L (0.20 mg/dL). But longevity research tells a different story.

2025–2026 update — tighter target, but not a screening mandate: The evidence no longer supports a single magic cutoff. A coronary microvascular study found that people in the highest “normal” homocysteine quartile (>9 µmol/L) had higher odds of coronary microvascular endothelial dysfunction, while a 2024 review argued that 10 µmol/L may be a more cautious clinical threshold than the historical 15 µmol/L. Musculoskeletal evidence is moving in the same direction: a 2025 meta-analysis linked homocysteine >14 µmol/L with higher sarcopenia risk in older adults, and 2026 Mendelian-randomization evidence supports a causal relationship between hyperhomocysteinemia (≥10 µmol/L) and sarcopenia traits. The practical takeaway is conservative: values above 10-12 µmol/L deserve context, repeat testing, and B-vitamin/kidney review, but homocysteine is still not a standalone screening target for everyone.

Why “Normal” Isn’t Optimal

Lab reference ranges are based on the statistical distribution of the population — not on health outcomes. They include sedentary people, smokers, individuals with vitamin deficiencies, and elderly with metabolic decline. Being within the “norm” simply means not being a statistical outlier.

Research shows that:

• Every increase of 5 µmol/L (0.07 mg/dL) is associated with a +20-30% coronary risk and +60% stroke risk
• Mortality risk for all causes begins to increase significantly above 12 µmol/L (0.16 mg/dL)
• The lowest risk levels are observed in the 4-8 µmol/L (0.05-0.11 mg/dL) range

How Homocysteine Changes with Age

Homocysteine tends to increase with age — a phenomenon linked to declining vitamin B12 absorption, reduced kidney function, and decreased enzymatic activity.

Age Range	Average Value	Optimal Value
20-40 years	6 - 10 µmol/L (0.08-0.13 mg/dL)	< 8 µmol/L (< 0.11 mg/dL)
40-60 years	8 - 12 µmol/L (0.11-0.16 mg/dL)	< 10 µmol/L (< 0.13 mg/dL)
60-75 years	10 - 16 µmol/L (0.13-0.21 mg/dL)	< 12 µmol/L (< 0.16 mg/dL)
75+ years	12 - 20 µmol/L (0.16-0.27 mg/dL)	< 14 µmol/L (< 0.19 mg/dL)

Key point: The fact that homocysteine increases with age doesn’t mean it’s “physiological” or acceptable. The increase is largely preventable with adequate B vitamin intake and healthy lifestyle.

---

The Centenarian Paradox: High Homocysteine and Long Life

Here’s one of the most counter-intuitive discoveries in aging research: the vast majority of centenarians have elevated homocysteine — yet they’ve reached extreme age.

The Numbers of the Paradox

Several studies have documented this phenomenon:

• A study published in Journals of Gerontology found that 77-100% of centenarians had elevated homocysteine (>17 µmol/L or >0.23 mg/dL) associated with low B12 and folate levels
• A Dutch study from the Leiden Longevity Study demonstrated that homocysteine levels did not differ between offspring of long-lived families and controls
• A French study on centenarians confirmed that elevated homocysteine levels were the norm, not the exception

How Is This Explained?

There are several hypotheses:

1. Protective genetic mechanisms Centenarians may possess genetic variants that protect them from the harmful effects of elevated homocysteine — for example, greater endogenous antioxidant capacity or blood vessels more resistant to oxidative stress.

2. Context matters more than single values Homocysteine may only be harmful in the presence of other risk factors (chronic inflammation, hypertension, diabetes). Centenarians, despite high homocysteine, often have low inflammation levels and good overall metabolic function.

3. Marker vs. cause Elevated homocysteine might be a marker of aging (like gray hair) rather than a direct cause. The Leiden study suggests exactly this: homocysteine rises with age in everyone, long-lived or not.

4. The functional threshold Even among centenarians, those with lower homocysteine (<23.8 µmol/L or <0.32 mg/dL) had better functional status — greater autonomy in daily activities. Homocysteine may not influence lifespan, but the quality of the final years.

The message: Don’t use the centenarian paradox as an excuse to ignore elevated homocysteine. Most of us don’t have the protective genetics of centenarians. For those who haven’t won the genetic lottery, optimizing homocysteine remains a prudent strategy.

---

Homocysteine and Epigenetic Aging: The 2024 Research

The most fascinating link between homocysteine and aging emerged from the VITACOG study, published in Aging Cell in 2024.

The VITACOG Study: B Vitamins Slow the Biological Clock

The VITACOG trial (VITAmins and COGnition) followed elderly individuals with mild cognitive impairment (MCI) for 2 years, randomized to receive high doses of B vitamins (folic acid, B6, B12) or placebo.

Key results:

• B vitamin treatment normalized homocysteine levels
• In treated participants, epigenetic aging (measured by Horvath and Hannum clocks) slowed compared to placebo
• The effect was more pronounced in subjects with initially elevated homocysteine
• B vitamins also significantly reduced brain atrophy

This is one of the first studies to demonstrate that a targeted nutritional intervention can not only modify a biomarker but slow aging at the epigenetic level.

2025 Follow-up: B Vitamins Work Beyond Homocysteine

A 2025 metabolomics analysis of VITACOG data, published in Alzheimer’s & Dementia, revealed that B vitamins reshape the brain’s metabolic environment far beyond simply lowering homocysteine. The intervention modulated central carbon metabolism, glutamine–glutamate cycling, and the kynurenine pathway — three systems tightly linked to neuroinflammation and neurodegeneration. In practice, B vitamins act on multiple aging-relevant pathways at once, helping explain why brain-atrophy slowing was so pronounced even when classical cardiovascular endpoints didn’t move in earlier trials.

Separately, a 2025 study in Nutrients tracked epigenetic age in adults with hyperhomocysteinemia who received folic acid supplementation. After treatment, average biological age dropped by 2.6 years, with 65% of participants classified as responders. Strikingly, in the initial “non-responder” subgroup (those whose homocysteine didn’t fall), 80% still showed an epigenetic age decrease averaging 5.3 years — suggesting folate’s anti-aging effect operates partly independently of measured homocysteine levels.

Homocysteine and Oxidative Stress

Homocysteine damages the body through several mechanisms:

Free radical (ROS) production:

• Homocysteine promotes NADPH oxidase activity — an enzyme that generates reactive oxygen species
• Reduces nitric oxide (NO) bioavailability — essential for vascular health
• Decreases thioredoxin expression — an intracellular antioxidant system

Synergistic effect with inflammation:

• Homocysteine >20 µmol/L (>0.27 mg/dL) + CRP >5 mg/L are the main determinants of superoxide production in the elderly
• Moderate hyperhomocysteinemia and chronic low-grade inflammation synergistically potentiate NADPH oxidase

Homocysteine and Endothelial Dysfunction

The endothelium — the inner lining of blood vessels — is one of the first targets of elevated homocysteine:

• Increased leukocyte adhesion — white blood cells stick to vessel walls
• Expression of adhesion molecules — promotes atherosclerosis
• Reduced nitric oxide — vasoconstriction and vascular stiffness
• Coagulation activation — increased thrombotic risk

---

Risks of High Homocysteine: Heart, Brain, Kidneys, and Bones

Hyperhomocysteinemia is associated with a broad spectrum of health risks, with particularly strong evidence for the cardiovascular system and brain.

Cardiovascular Disease

The association between homocysteine and cardiovascular risk is one of the most studied in medicine:

• Every +5 µmol/L (+0.07 mg/dL) = +20-30% coronary risk and +60% stroke risk
• An “umbrella” review from 2025 confirmed the association across multiple cardiovascular outcomes
• Homocysteine promotes atherosclerosis, thrombosis, and endothelial dysfunction
• Mendelian randomization studies now provide causal evidence: genetically predicted homocysteine raises any-stroke risk (OR 1.11 per 1 SD) and small-vessel stroke in particular (OR 1.34, 95% CI 1.13–1.58) — meaning the relationship is not just associative

The treatment paradox: Despite the robust association, most clinical trials show that lowering homocysteine with B vitamins does not consistently reduce cardiovascular events. A 2026 meta-analysis pooling 13 RCTs and 14,539 participants confirmed this nuance: combined B-vitamin supplementation dropped homocysteine by 2.36 µmol/L on average and reduced vascular restenosis (RR 0.65), but produced no significant change in major cardiovascular events or mortality. This suggests homocysteine might be a risk marker rather than a direct cause — or that cardiovascular damage, once established, isn’t completely reversible.

Important note: This doesn’t mean ignoring high homocysteine is wise. The lack of benefit in trials may reflect the fact that participants already had advanced vascular damage. Primary prevention — keeping homocysteine low from youth — might have a very different impact. Major bodies like the American Heart Association still advise against routine homocysteine screening or B-vitamin supplementation as standalone cardiovascular prevention, framing homocysteine as a marker to interpret within a broader cardiometabolic context rather than an isolated drug target.

Cognitive Decline and Dementia

The brain is particularly vulnerable to elevated homocysteine:

• Homocysteine is converted to homocysteic acid, a potent NMDA receptor agonist that causes neuronal excitotoxicity
• Excess NMDA stimulation causes massive calcium influx into nerve cells → neuronal death
• A 2024 meta-analysis confirms that elevated homocysteine increases Alzheimer’s risk
• The VITACOG trial demonstrated that B vitamins reduce brain atrophy by 31% in subjects with MCI and elevated homocysteine — and by more than 7-fold in AD-vulnerable regions for those with above-median homocysteine
• A 2025 consensus paper (Smith, McCaddon, Refsum and colleagues) argued the Lancet Commission omitted homocysteine from its 2024 modifiable dementia risk factors despite robust evidence — citing UK Biobank data on 192,214 adults showing dietary B-vitamin/methionine intake reduced Alzheimer’s hazard ratios to 0.30–0.77, and a Swedish cohort where the top quartile of homocysteine carried 60% higher dementia risk
• The current threshold suggested for B-vitamin intervention trials in MCI is homocysteine > 11 µmol/L

Kidney Function

The relationship between homocysteine and kidneys is bidirectional:

• Kidneys are responsible for about 70% of homocysteine clearance
• When kidney function declines, homocysteine accumulates
• But elevated homocysteine (>14.3 µmol/L or >0.19 mg/dL) is also an independent risk factor for chronic kidney disease
• Kidney decline further accelerates homocysteine accumulation → vicious cycle

Link to creatinine: Homocysteine and creatinine are closely correlated: both increase when kidneys function less. Monitoring them together provides a more complete picture of kidney health.

Bone Health

Elevated homocysteine is associated with:

• Reduced bone mineral density
• Increased fracture risk, especially in the elderly
• Interference with bone collagen cross-linking

---

Causes of Elevated Homocysteine

Homocysteine accumulation can have several origins, often concurrent.

Vitamin Deficiencies (The Most Common Cause)

The three B vitamins essential for homocysteine metabolism are:

Vitamin	Role	Consequence of Deficiency
Folate (B9)	Donates methyl group to recycle homocysteine → methionine	Most frequent cause of hyperhomocysteinemia
Vitamin B12	Cofactor of methionine synthase (remethylation)	Common in elderly and vegans
Vitamin B6	Cofactor of CBS (transsulfuration)	Less common, but important
Vitamin B2	Cofactor of MTHFR enzyme	Often overlooked

MTHFR Mutations: The Genetic Component

The MTHFR enzyme (methylenetetrahydrofolate reductase) is the bottleneck of the methylation cycle. It converts folate to its active form (5-MTHF), needed to recycle homocysteine.

C677T Variant:

• CT (heterozygous): ~65% of normal enzymatic activity — mild homocysteine increase
• TT (homozygous): ~30% of normal enzymatic activity — significant homocysteine increase
• Population frequency: 30-40% carry at least one copy of the variant

A1298C Variant:

• Lower impact on homocysteine compared to C677T
• The combination of both variants has an additive effect

Practical implications:

• Those with the TT variant and persistently high homocysteine may benefit from discussing methylated folate (5-MTHF) with a clinician
• Routine MTHFR testing is not recommended for most people; homocysteine level, B12, folate, kidney function, thyroid status, and medication review usually matter more
• Not all carriers have elevated homocysteine — it depends on folate intake and other factors

Other Causes

• Advanced age — reduced B12 absorption, kidney decline, decreased enzymatic activity
• Kidney failure — kidneys eliminate 70% of homocysteine
• Hypothyroidism — slows homocysteine metabolism
• Medications — methotrexate, antiepileptics, oral contraceptives, proton pump inhibitors (reduce B12 absorption)
• Smoking — reduces folate and B6 levels
• Excessive alcohol — interferes with B vitamin absorption and metabolism
• Excess coffee — >6 cups per day associated with higher homocysteine

---

How to Lower Homocysteine Naturally: 7 Evidence-Based Strategies

Homocysteine is one of the most modifiable biomarkers. In most cases, correcting vitamin deficiencies and adopting a healthy lifestyle is sufficient to bring it back to the optimal range.

1. Increase Folate (Vitamin B9) Intake

Why it works: Folate is the main substrate for recycling homocysteine to methionine. Folate deficiency is the most frequent cause of hyperhomocysteinemia.

How to do it:

• Goal: 400-800 µg/day from food (up to 1,000 µg with supplementation)
• Cooked spinach: 194 µg per cup (about 50% of needs)
• Cooked lentils: 358 µg per cup
• Asparagus: 134 µg per cup
• Cooked broccoli: 168 µg per cup
• Oranges and citrus: good natural sources

Note on supplementation: People with known MTHFR variants sometimes prefer 5-MTHF (methylfolate), but standard folic acid still raises blood folate for most people. Choose supplement form with a clinician if you’re pregnant, taking interacting medications, or homocysteine stays high despite adequate B12 and folate intake.

2. Optimize Vitamin B12

Why it works: B12 is an essential cofactor of methionine synthase. Without B12, the remethylation cycle blocks and homocysteine accumulates.

How to do it:

• Goal: 2.4 µg/day (minimum requirement), 500-1,000 µg for optimization
• Beef liver: ~70 µg per 100 g (3.5 oz) (small amounts are sufficient)
• Sardines/mackerel: 8-18 µg per 100 g (3.5 oz)
• Eggs: ~1.1 µg per egg
• Dairy: 0.3-1.2 µg per serving

Who is at higher risk of deficiency:

• Vegans and vegetarians — plant sources have almost no active B12
• Over 60 — reduced gastric absorption (up to 30% of elderly)
• Those taking proton pump inhibitors — reduce absorption

3. Don’t Forget Vitamin B6

Why it works: B6 is necessary for the transsulfuration pathway — the second homocysteine clearance route, which converts it to cysteine.

How to do it:

• Goal: 1.3-2 mg/day
• Chickpeas: 1.1 mg per cup
• Salmon: 0.6 mg per 100 g (3.5 oz)
• Potatoes: 0.4 mg per medium potato
• Bananas: 0.4 mg per banana
• Chicken breast: 0.5 mg per 100 g (3.5 oz)

4. Consider Betaine (TMG)

Why it works: Trimethylglycine (TMG, also called betaine) is an alternative methyl donor that can recycle homocysteine to methionine through a pathway independent of B12 and folate.

How to do it:

• Food sources: beets, quinoa, wheat bran, spinach
• Supplementation: 500-3,000 mg/day of TMG (under medical supervision)
• Particularly useful for those with MTHFR mutations or who don’t respond completely to B vitamins

5. Regular Physical Activity

Why it works: Regular exercise is associated with lower homocysteine levels, independent of diet. One study showed that a combination of plant-based diet and moderate exercise reduced homocysteine by 13%.

How to do it:

• 150-300 minutes/week of moderate activity (brisk walking at 3.1-3.7 mph / 5-6 km/h)
• 2-3 sessions/week of resistance training
• Avoid prolonged sedentary behavior — stand up every 60 minutes

6. Eliminate or Reduce Aggravating Factors

Why it works: Some lifestyle factors increase homocysteine or worsen the vitamin deficiencies that cause it.

What to do:

• Stop smoking — smoking reduces blood folate and B6 levels
• Limit alcohol — alcohol interferes with B vitamin absorption and metabolism
• Moderate coffee — limit to 3-4 cups per day (>6 cups associated with higher homocysteine)
• Reduce red meat — rich in methionine, the precursor of homocysteine

7. Monitor and Personalize

Why it works: Homocysteine responds differently depending on the underlying cause. A personalized approach is much more effective than generic supplementation.

How to do it:

• Test homocysteine before starting any supplementation
• Repeat after 3 months to verify response
• Discuss selective MTHFR testing only if homocysteine stays high after B vitamin status, kidney function, thyroid status, and medications have been reviewed
• Also check B12, folate, and kidney function (creatinine, eGFR)

Advanced tip: Folic acid fortification has lowered average homocysteine in populations, but MTHFR status alone does not determine response. If homocysteine stays high despite adequate B12 and folate, a clinician may consider methylfolate, riboflavin, betaine, medication review, and selective genetic testing.

---

When to Test and How to Interpret Results

Who Should Test Homocysteine?

Homocysteine is not part of routine blood tests in most countries. It must be specifically requested. It’s recommended for:

Medical indications:

• Personal or family history of early cardiovascular disease
• Unexplained venous or arterial thrombosis
• Atherosclerosis without traditional risk factors
• Stroke or heart attacks
• Hypertension, diabetes, high cholesterol

Nutritional/genetic indications:

• Vegan or vegetarian diet (B12 deficiency risk)
• Over 60 (reduced B12 absorption)
• Chronic use of medications that interfere with B vitamins
• Persistently elevated homocysteine despite correcting B vitamin intake

Longevity indications:

• Those monitoring their biological age
• Those optimizing blood biomarkers preventively
• After age 40, as part of a comprehensive longevity panel

How to Prepare for the Test

• Fasting: generally required (8-12 hours), because intake of methionine-rich food can temporarily alter levels
• Inform your doctor: medications in use (especially methotrexate, antiepileptics, PPIs)
• Avoid B vitamin supplements in the 24 hours prior (they can artificially lower the value)

How to Interpret Results

Homocysteine (µmol/L)	What to Do
< 8 (< 0.11 mg/dL)	Optimal — maintain current lifestyle, recheck annually
8 - 12 (0.11-0.16 mg/dL)	Suboptimal — optimize diet, consider targeted supplementation, repeat at 6 months
12 - 15 (0.16-0.20 mg/dL)	Elevated — start supplementation with B9 + B12 + B6, investigate causes, repeat at 3 months
15 - 30 (0.20-0.40 mg/dL)	High — consult doctor, supplement if deficient, rule out kidney/thyroid causes, consider selective genetic testing only if unexplained
> 30 (> 0.40 mg/dL)	Very high — urgent investigations (kidney function, homocystinuria, severe deficiencies)

Complementary Tests

For a complete picture, along with homocysteine it’s useful to measure:

• Serum folate — the most common cause of hyperhomocysteinemia
• Vitamin B12 — second most frequent cause
• Creatinine and eGFR — kidney function
• TSH — rule out hypothyroidism
• CRP — inflammatory status (synergism with homocysteine)
• Selective MTHFR genetic test — only if homocysteine remains unexplained after the more common causes have been addressed

---

How SuperAge Integrates Homocysteine into the Longevity Picture

Homocysteine isn’t directly part of the PhenoAge algorithm — but it’s deeply connected to the biomarkers that compose it. Here’s how SuperAge helps you use it in the context of your biological age.

The Connection to PhenoAge

Homocysteine indirectly influences several PhenoAge biomarkers:

• Creatinine — elevated homocysteine accelerates kidney decline, which increases creatinine
• CRP (C-reactive protein) — hyperhomocysteinemia potentiates inflammation, which raises CRP
• Albumin — chronic inflammation induced by homocysteine reduces albumin production
• White blood cells — oxidative stress from homocysteine influences leukocyte counts

In practice: optimizing homocysteine can indirectly improve your PhenoAge through the cascade effect on these biomarkers.

Monitoring Over Time with SuperAge

SuperAge uses Apple’s artificial intelligence to automatically extract biomarkers from your blood test reports — including homocysteine. Just take a photo or upload the PDF:

• Automatic recognition of values in any language and format
• Unit conversion — whether your lab uses µmol/L or mg/dL
• Trends over time — see if homocysteine is rising or falling over months
• Correlation with PhenoAge — observe how homocysteine changes reflect on your biological age

Integrated Strategy

SuperAge’s approach is holistic: it doesn’t look at single values, but the overall picture of your biomarkers over time. Homocysteine fits into a network of interconnected parameters — and the real value is in monitoring them all together.

Want to discover how homocysteine influences your biological age? Download SuperAge and upload your blood tests to calculate your PhenoAge.

---

Frequently Asked Questions

What is homocysteine in blood tests?

Homocysteine is a sulfur-containing amino acid produced from methionine metabolism. It’s measured with a simple venous blood draw. Elevated levels indicate problems in methylation — the biochemical process that regulates gene expression, neurotransmitter production, and liver detoxification. It’s a marker of cardiovascular, cognitive, and accelerated aging risk.

What are normal homocysteine values?

The “normal” lab range is 5-15 µmol/L (0.07-0.20 mg/dL). However, longevity research suggests that optimal values are between 4 and 8 µmol/L (0.05-0.11 mg/dL). Every 5 µmol/L (0.07 mg/dL) increase above this range is associated with +20-30% coronary risk. After age 60, levels tend to rise naturally, but this increase is largely preventable.

Is high homocysteine dangerous?

It depends on context. Levels between 12 and 15 µmol/L (0.16-0.20 mg/dL) deserve attention and optimization. Above 15 µmol/L (0.20 mg/dL) it’s called hyperhomocysteinemia, associated with cardiovascular risk, cognitive decline, and kidney damage. Above 30 µmol/L (0.40 mg/dL) requires urgent medical investigation. That said, the association between homocysteine and disease doesn’t necessarily imply a direct causal relationship — it may partly be a marker rather than a cause.

How do you lower homocysteine?

In most cases, correcting B vitamin deficiencies is sufficient. Folate (B9) is the most important, followed by B12 and B6. A diet rich in leafy green vegetables, legumes, fish, and eggs covers most needs. For those with MTHFR mutations, methylfolate (5-MTHF) is preferable to synthetic folic acid. Exercise, smoking cessation, and alcohol reduction also help.

What is the MTHFR mutation and how does it affect homocysteine?

MTHFR is an enzyme that converts folate to its active form (5-MTHF). 30-40% of the population has a genetic variant (C677T) that can reduce this enzyme’s activity, and homozygous carriers (TT) may be more prone to elevated homocysteine. But common MTHFR variants do not automatically mean disease or require special treatment. Most medical sources do not recommend routine testing; checking homocysteine, B12, folate, kidney function, thyroid status, and medications is usually more useful. If homocysteine remains high despite correcting those factors, a clinician may consider MTHFR testing or methylfolate.

Why do centenarians have high homocysteine?

It’s the so-called “centenarian paradox.” 77-100% of them have homocysteine >17 µmol/L (>0.23 mg/dL), but live past 100 years. Hypotheses include: protective genetic mechanisms, low systemic inflammation that mitigates damage, and the fact that homocysteine might be a marker of aging rather than a direct cause. Even among centenarians, however, those with relatively lower homocysteine have better functional status.

Is homocysteine included in PhenoAge calculation?

No, homocysteine is not part of the 9 biomarkers of the PhenoAge algorithm. However, it indirectly influences several PhenoAge parameters (creatinine, CRP, albumin, white blood cells) through its effects on kidneys, inflammation, and oxidative stress. The 2024 VITACOG study demonstrated that normalizing homocysteine slows epigenetic aging measured by clocks independent of PhenoAge.

How often should you check homocysteine?

If values are optimal (<8 µmol/L or <0.11 mg/dL): once a year. If suboptimal (8-15 µmol/L or 0.11-0.20 mg/dL): every 6 months, especially if you’ve started supplementation. If elevated (>15 µmol/L or >0.20 mg/dL): every 3 months until normalization. After age 50, it’s prudent to include homocysteine in the annual longevity panel along with PhenoAge, vitamin B12, folate, and kidney function.

---

Key Takeaways

• Homocysteine is a key amino acid in the methylation cycle — the process that regulates gene expression, neurotransmitter production, and epigenetic aging
• “Normal” lab values (up to 15 µmol/L or 0.20 mg/dL) aren’t optimal: the ideal range for longevity is 4-8 µmol/L (0.05-0.11 mg/dL)
• The centenarian paradox shows that genetics can protect from the effects of elevated homocysteine — but most of us don’t have this protection
• The VITACOG study (2024) demonstrated that normalizing homocysteine with B vitamins slows epigenetic aging
• Every +5 µmol/L (+0.07 mg/dL) = +20-30% coronary risk and +60% stroke risk
• B vitamins are the key: folate (B9), B12, and B6 are essential for clearing homocysteine
• 30-40% of the population carries common MTHFR variants, but the homocysteine response matters more than genotype alone
• Homocysteine is highly modifiable: diet, supplementation, and lifestyle can bring it back to optimal range in 3-6 months

---

Start Monitoring Your Homocysteine Today

Homocysteine is one of those biomarkers at the crossroads between nutrition, genetics, and aging. Unlike many blood parameters, it’s highly modifiable — in most cases, the right vitamins and healthy lifestyle are enough to bring it back to the optimal range.

Next time you get blood tests, ask your doctor to include homocysteine. And don’t settle for “it’s in the normal range” — ask for the exact value, compare it with the optimal range (4-8 µmol/L or 0.05-0.11 mg/dL), and start monitoring the trend over time.

Want to integrate homocysteine into your biological age picture? Download SuperAge and calculate your PhenoAge from blood tests.

---

References

1. Smith, A. D. et al. (2024). “B-vitamins slow epigenetic aging: the VITACOG trial.” Aging Cell. DOI: 10.1111/acel.14255
2. McCully, K. S. (2009). “Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation.” Annals of Clinical and Laboratory Science, 39(3), 219-232.
3. Perna, A. F. et al. (2003). “Homocysteine and oxidative stress.” Amino Acids, 25, 409-417. DOI: 10.1007/s00726-003-0026-8
4. Van Uffelen, J. G. et al. (2011). “Homocysteine levels in offspring from families with exceptional longevity: the Leiden Longevity Study.” PLoS ONE. DOI: 10.1371/journal.pone.0017543
5. Bates, C. J. et al. (2002). “Homocysteine, B-vitamins, and centenarians.” Journals of Gerontology. DOI: 10.1093/gerona/57.2.M76
6. Levine, M. E. et al. (2018). “An epigenetic biomarker of aging for lifespan and healthspan.” Aging, 10(4), 573-591. DOI: 10.18632/aging.101414
7. Ganguly, P. & Alam, S. F. (2015). “Role of homocysteine in the development of cardiovascular disease.” Nutrition Journal, 14, 6. DOI: 10.1186/1475-2891-14-6
8. Seshadri, S. et al. (2002). “Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease.” New England Journal of Medicine, 346(7), 476-483. DOI: 10.1056/NEJMoa011613
9. Wald, D. S. et al. (2002). “Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.” BMJ, 325, 1202. DOI: 10.1136/bmj.325.7374.1202
10. Frosst, P. et al. (1995). “A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.” Nature Genetics, 10, 111-113. DOI: 10.1038/ng0595-111
11. Miller, J. W., McCaddon, A., Yu, J.-T., Hooshmand, B., Refsum, H., & Smith, A. D. (2025). “Concerning the debate about homocysteine, B vitamins, and dementia.” Journal of Alzheimer’s Disease. DOI: 10.1177/13872877251350297
12. Kacerova, T. et al. (2025). “Role of B vitamins in modulating homocysteine and metabolic pathways linked to brain atrophy: Metabolomics insights from the VITACOG trial.” Alzheimer’s & Dementia. DOI: 10.1002/alz.70521
13. (2024). “Hyperhomocysteinemia and Disease — Is 10 µmol/L a Suitable New Threshold Limit?” Nutrients. PMC11594664
14. (2026). “Combined B-vitamin supplementation on homocysteine and vascular outcomes in coronary heart disease: a meta-analysis.” PubMed. PMID 41615824
15. (2025). “Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption.” Nutrients, 17(13), 2133. DOI: 10.3390/nu17132133
16. Larsson, S. C. et al. (2019, updated MR evidence 2025). “Homocysteine and small vessel stroke: A mendelian randomization analysis.” Annals of Neurology. DOI: 10.1002/ana.25440
17. (2026). “Genetically Predicted Homocysteine Levels and B Vitamins on Sarcopenia-Related Traits: Insights From an Observational and Mendelian Randomization Analysis.” PMC12907574
18. MedlinePlus. (2026). “MTHFR Gene Test.” https://medlineplus.gov/lab-tests/mthfr-gene-test/
19. Hickey, S. E., Curry, C. J., & Toriello, H. V. (2013). “ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.” Genetics in Medicine. PMID 23288205

---

Last updated: June 2026. This article is regularly reviewed for accuracy. The information provided does not replace professional medical advice.